Ikram H, Webster MW, Nicholls MG, Lewis GR, Richards AM, Crozier IG. Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 1986;
16:61-3. [PMID:
3010929 DOI:
10.1111/j.1445-5994.1986.tb01119.x]
[Citation(s) in RCA: 27] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Three cases are described of severe congestive heart failure which failed to respond to digitalis, high doses of loop diuretics, and converting-enzyme inhibitors. The addition of spironolactone produced a substantial diuresis associated with clinical and radiological improvement in each case. Although a reversible deterioration in renal function was observed, this drug combination represents a therapeutic option in end-stage heart failure.
Collapse